Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05950503

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Detailed description

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Conditions

Interventions

TypeNameDescription
RADIATIONHepatic MRIThe patients will undergo hepatic MRI in pre-established timepoints

Timeline

Start date
2023-07-10
Primary completion
2026-06-07
Completion
2027-06-07
First posted
2023-07-18
Last updated
2025-09-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05950503. Inclusion in this directory is not an endorsement.

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer (NCT05950503) · Clinical Trials Directory